These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19136639)

  • 1. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
    Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
    Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme.
    Gera L; Bawolak MT; Roy C; Lodge R; Marceau F
    J Pharmacol Exp Ther; 2011 Apr; 337(1):33-41. PubMed ID: 21205920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.
    Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F
    Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle.
    Koumbadinga GA; Petitclerc E; Bouthillier J; Adam A; Marceau F
    Eur J Pharmacol; 2009 Mar; 606(1-3):233-9. PubMed ID: 19374866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
    Reyes-Cruz G; Vázquez-Prado J; Müller-Esterl W; Vaca L
    J Cell Biochem; 2000 Jan; 76(4):658-73. PubMed ID: 10653985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration.
    Bertram CM; Baltic S; Misso NL; Bhoola KD; Foster PS; Thompson PJ; Fogel-Petrovic M
    J Leukoc Biol; 2007 Jun; 81(6):1445-54. PubMed ID: 17327486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does zaltoprofen antagonize the bradykinin receptors?
    Bawolak MT; Marceau F
    Regul Pept; 2007 May; 140(3):125-30. PubMed ID: 17258326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle.
    Meini S; Cucchi P; Catalani C; Bellucci F; Santicioli P; Giuliani S; Maggi CA
    Eur J Pharmacol; 2010 Jun; 635(1-3):34-9. PubMed ID: 20307535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.
    Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; Adam A; Marceau F
    J Pharmacol Exp Ther; 2001 Apr; 297(1):19-26. PubMed ID: 11259523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.
    Marceau F; Fortin JP; Morissette G; Dziadulewicz EK
    Int Immunopharmacol; 2003 Oct; 3(10-11):1529-36. PubMed ID: 12946450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of kinin receptors in human cultured detrusor smooth muscle cells.
    Bellucci F; Cucchi P; Santicioli P; Lazzeri M; Turini D; Meini S
    Br J Pharmacol; 2007 Jan; 150(2):192-9. PubMed ID: 17179953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.